Glucagon-Like Peptide-1 Receptor Agonists May Reduce Alcohol Consumption
By Lori Solomon HealthDay Reporter
THURSDAY, Nov. 21, 2024 -- Glucagon-like peptide-1 receptor agonist (GLP-1 RA) use may reduce alcohol consumption and improve outcomes in some individuals, according to a study published online Nov. 14 in eClinicalMedicine.
Mohsan Subhani, M.B.B.S., from the University of Nottingham in the United Kingdom, and colleagues conducted a systematic literature review to evaluate the existing literature on the association between GLP-1 RAs and alcohol consumption.
The researchers identified six studies (88,190 participants; 43.9 percent receiving GLP-1 RAs). However, only 286 participated in randomized controlled trials (RCTs), which did not show a reduction in alcohol consumption over 30 days after 24 weeks of treatment with exenatide versus placebo. In a subgroup analysis, there was a positive effect in people with obesity, with significant reductions in brain reward center cue reactivity on functional magnetic resonance imaging. Among RCT participants, those taking dulaglutide were more likely to reduce alcohol intake compared with placebo (relative effect size, 0.71). Fewer alcohol-related health care events and a significant reduction in alcohol use were seen in observational studies comparing GLP-1 RA treatment to dipeptidyl peptidase 4 use, no treatment, and/or alcohol intake at baseline.
"There is little high-quality evidence demonstrating the effect of GLP-1 RAs on alcohol use," the authors write.
Several authors disclosed ties to the pharmaceutical industry.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted November 2024
Read this next
Hypertension Deaths From Excessive Alcohol Use Are Increasing
THURSDAY, July 3, 2025 -- The estimated mean annual number of hypertension deaths from excessive alcohol use was higher in 2020-2021 than in 2016-2017, with a higher increase...
Menstrual Cycle Phases May Be Linked to Higher Alcohol Craving, Drinking
TUESDAY, July 1, 2025 -- Fluctuations in ovarian sex hormones across the menstrual cycle may influence women’s likelihood of alcohol consumption, according to a study...
Alcoholic Liver Disease Mortality Increased Across Demographic Groups
TUESDAY, June 17, 2025 -- Alcohol-associated liver disease (ALD) mortality increased significantly from 2019 to 2022, according to a study published online June 11 in JAMA Network...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.